2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS

The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. La présente invention concerne des inhibiteurs de SHP2 et leur utilisation dans le traitement de maladies. La présente invention con...

Full description

Saved in:
Bibliographic Details
Main Authors KISS, Gert, GILL, Adrian, MELLEM, Kevin, AAY, Naing, SEMKO, Christopher, WON, Walter, JOGALEKAR, Ash, BUCKL, Andreas, KOLTUN, Elena S
Format Patent
LanguageEnglish
French
Published 18.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. La présente invention concerne des inhibiteurs de SHP2 et leur utilisation dans le traitement de maladies. La présente invention concerne en outre des compositions pharmaceutiques comprenant ceux-ci.
AbstractList The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. La présente invention concerne des inhibiteurs de SHP2 et leur utilisation dans le traitement de maladies. La présente invention concerne en outre des compositions pharmaceutiques comprenant ceux-ci.
Author BUCKL, Andreas
KOLTUN, Elena S
AAY, Naing
JOGALEKAR, Ash
SEMKO, Christopher
GILL, Adrian
MELLEM, Kevin
KISS, Gert
WON, Walter
Author_xml – fullname: KISS, Gert
– fullname: GILL, Adrian
– fullname: MELLEM, Kevin
– fullname: AAY, Naing
– fullname: SEMKO, Christopher
– fullname: WON, Walter
– fullname: JOGALEKAR, Ash
– fullname: BUCKL, Andreas
– fullname: KOLTUN, Elena S
BookMark eNrjYmDJy89L5WTIM9Ix1XXxDA51Cg7xDAkNcXVRMNb1dQ3xiPRRCIgMcozy9HMNVnD0c1EAKtQx0w0JIqgWiHx8_INDXIM8nRWCPQKMFDz9PDydPEP8g4J5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgaGFgaGxqaW5o6ExcaoAgyM5yg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 3-MÉTHYLPYRAZINES 2,5-DISUBSTITUÉES ET 3-MÉTHYL PYRAZINES 2,5,6-TRISUBSTITUÉS EN TANT QU'INHIBITEURS ALLOSTÉRIQUES DE SHP2
ExternalDocumentID WO2018013597A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2018013597A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:42:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2018013597A13
Notes Application Number: WO2017US41577
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180118&DB=EPODOC&CC=WO&NR=2018013597A1
ParticipantIDs epo_espacenet_WO2018013597A1
PublicationCentury 2000
PublicationDate 20180118
PublicationDateYYYYMMDD 2018-01-18
PublicationDate_xml – month: 01
  year: 2018
  text: 20180118
  day: 18
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies JOGALEKAR, Ash
REVOLUTION MEDICINES, INC
WON, Walter
RelatedCompanies_xml – name: WON, Walter
– name: REVOLUTION MEDICINES, INC
– name: JOGALEKAR, Ash
Score 3.1215682
Snippet The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180118&DB=EPODOC&locale=&CC=WO&NR=2018013597A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwEA9jivqmU_FjSkDp04pmTbf2Ycj6MVrZ2tJmuvkymn6AIN1wFf99L6XTPU3IQ5ILIQnc5X6XuwtC9_kjV1LST2Sa6CoAFJXIcdZPAaWkWVfnlOSJCHCeeD1nSp9n6qyBPjaxMFWe0O8qOSJwVAL8XlbyevVnxLIq38r1A3-HruXTiA0sqUbHRBOBlJJlDOzAt3xTMk3AbZIX1jQF1OchYKU9oUiLTPv2iyHiUlbbl8roGO0HMF9RnqBGVrTQobn5e62FDib1kzdUa-5bn6Ki21Fly42mRsRcNgWZgxV5YjNnPsbBPBy-iR808NCzMAzs9GQW_jsWynjsR0z4leLICbrY9RzXcJkfRmfobmQz05Fh4Yvfc1q8-tu7VM5Rs1gW2QXCOmw2ToTmo-dUywmnPNNinidcoTQn8SVq75rpajf5Gh2JprBLEK2NmuXnV3YDN3XJb6sD_gHwN46F
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED_GFPVNp-LH1ILSpxXtmm7rw5C13Wi1X7SZbr6MpmtBkG64iv--l9LpnibkIeSOkBxc7n7J3QXgLntgylzuJhJJNBUBiipLcdqdI0qZp22NETlLeIKz63WsMXmaqJMafKxzYco6od9lcUTUqAT1vSjP6-XfJZZZxlau7tk7Di0eR7RvihU6lns8kVI09f4w8E3fEA0DcZvohRVNQfd5gFhpp8vr83Ln6UXneSnLTaMyOoTdAOfLiyOopXkD9o3132sN2HOrJ2_sVtq3Ooa83VIl047GekRtOsYzR1Akd0itqSME03Dwxn_QEAaeKSBjqyPR8F9ebI7jR5THlQqRFbQF27Ns3aZ-GJ3A7WhIDUvChc9-5TR79Td3qZxCPV_k6RkImqqROOGej5aRXiYzwtJezLKEKYRkcnwOzW0zXWwn38C-RV1n5tje8yUccBK_o5B7TagXn1_pFVrtgl2Xwv4Bw9iRcg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2%2C5-DISUBSTITUTED+3-METHYL+PYRAZINES+AND+2%2C5%2C6-TRISUBSTITUTED+3-METHYL+PYRAZINES+AS+ALLOSTERIC+SHP2+INHIBITORS&rft.inventor=KISS%2C+Gert&rft.inventor=GILL%2C+Adrian&rft.inventor=MELLEM%2C+Kevin&rft.inventor=AAY%2C+Naing&rft.inventor=SEMKO%2C+Christopher&rft.inventor=WON%2C+Walter&rft.inventor=JOGALEKAR%2C+Ash&rft.inventor=BUCKL%2C+Andreas&rft.inventor=KOLTUN%2C+Elena+S&rft.date=2018-01-18&rft.externalDBID=A1&rft.externalDocID=WO2018013597A1